Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Benefit-Risk Math: US FDA Still Favors Simple Calculations

May 29 2019

• By Cole Werble

Mathematical scientific pattern

Related Content

US FDA's Benefit/Risk Framework Gets High Marks But Could Be Improved

Sep 20 2017

Patient Experience Data: Industry Seeks US FDA Clarity On Submission Pathway And Labeling

Mar 19 2018

Benefit-Risk Frameworks May Be Coming To US FDA Advisory Committees

Apr 03 2018

US FDA's Benefit-Risk Assessment Could Include More Emphasis on Patient Involvement

May 29 2019

Related Companies

Johnson & Johnson

Additional Topics

United States Drug Approval Standards Drug Review Drug Safety Regulation BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window